BULLETIN R&D FARMASI HKL 2019

“Without data, you’re just another person with an opinion”


-W. Edwards Deming



Pharmacy R&D Committee members


Honorary Patron
First and foremost, praises and thanks to Allah
Pn. Kamarunnesa Binti Mokhtar Ahmad
The Almighty, for showering us with blessings through-

Chairperson out a journey filled with knowledge and joy.
Dr. Norkasihan Binti Ibrahim A profession that doesn’t uphold research activities will
eventually extinct. This is so true because research opens the opportunity to

Secretary evolve according to the current demand and effectively expand existing services
to fulfil expectation. Research brings together observations, knowledge and data
Hoo Mei Huey
to solve problems, invent solutions and develop new products. I truly encourage

Committee Members all pharmacists, young and senior alike, to embrace R&D culture for without
Pn. Rohana Hassan sound data, our plans and actions are merely based on opinions with high
chances of improper utilisation of resources and even failure. With the above
Dr Suzana Mustafa mentioned statements, let us agree on the importance of evidence based
Dr. Zaitulhusna Md Safee improvements.
Dr. Shamala A/p Balan
Pn. Nirmala A/p Jagan I would like to thank the Pharmacy R&D Committee for their hard work
in upscaling the quality of pharmacy research and congratulations on the
Cik Siti Shahida Md. Shariffudin
printing of this bulletin. Congratulations to all achievers for shedding the limelight
Cik Jasmine Ching Shan Lii to the profession at various platforms. My appreciation also goes to each and
Cik Hannah Abd Halim
every one of you for your support and participation in research activities
Pn. Hoo Mei Huey regardless big or small. Last but not least, let us aspire to be best from better
En. Ashraf Abdul Rahman and inspire each other to be great!
En. Rubhain A/l Mageswaran
Cik Teoh Woan Jih “Research is to see what everybody else has seen, and to think what
nobody has thought” …. quote
En. Muhammad Aszuat Mohd Khalid


KAMARUNESSA MOKHTAR AHMAD
Deputy Director (Pharmacy)
Hospital Kuala Lumpur


Board of Editorial

Editor
Dr. Norkasihan Binti Ibrahim

Editorial Members
Ashraf Abdul Rahman
Teoh Woan jih
Hoo Mei Huey
M. Aszuat M. Khalid back: En. Ashraf, Cik Khodrul, Pn. Nirmala, Cik Siti Shahida, Dr. Shamala, Pn. Hoo, En. Aszuat,
Front: Pn. Rohana, Dr. Zaitul, Pn. Kamarunnesa, Dr. Norkasihan, Cik Jasmine
Nurkhodrulnada M. Lattepi
Not in the pic. Dr.Suzana, Cik Hannah, En. Rhubain, Cik Teoh,

CONTENTS




 Foreword

Word of Deputy Director (Pharmacy) Pg 3 Dear fellow colleagues,

On behalf of the Pharmacy R&D
 Editor’s Desk Committee, I am glad to present the first edition of

From Editor’s Desk Pg 4 our bulletin. The journey of this bulletin took
almost a year from imagination to reality and it
would not have been materialised without the

hard work of the committee members. I must note
 Achievements
here that the backbone of this committee are pharmacists and pharmacy
Award & Achievements pg 5 technicians from the golden triangle i.e. Hospital Kuala Lumpur (HKL), Women
& Children Hospital (WCH) and Institute of Respiratory Medicine (IPR).

 Participation We hope that this bulletin would prosper the passion and resonates
the excitement for research amongst us. The content would bring you closer to
R&D Participations Pg 8
the vision about incorporating research in daily practice. We also bring you
announcements of achievements and performance as well as the steps to
register new research.
 List of Research
We would like to take this opportunity to express appreciation to Puan
List of R&D Submission(’16—’19) pg 9
Kamarunessa Mokhtar Ahmad, HKL Deputy Director (Pharmacy) for her
motherly approach and advice in making the impossible possible. Our heartfelt
gratitude to Puan Rohana, Dr Suzana, Dr Zaitulhusna, Cik Khodrulnada and
 Research Registration
Encik Ashraf for the contributions during their terms with us. We must also
Steps of Registration pg 12
acknowledge dear colleagues who have taken part in many ways from
participating and supporting R&D activities to most importantly, conducting the

research. Kudos to our ‘research geeks’ for your grit in going through the
 Year Plan
challenges and congratulations on your achievements. Our gratitude extends
R&D Annual Calendar pg 13 to HKL CRC for the continuous training programs and guidance; and also our
collaborators within HKL and the academia counterparts. All the best to us for

year 2020!

DR NORKASIHAN IBRAHIM
Pharmacy R&D Committee
HKL, WCH & IPR











Disclaimer
From left: Aszuat, Khodrul, Ally Teoh, Dr Norkasihan (Mid Front), Mei Huey, Ashraf
All data and presentation in this publication are correct
upon printing. Any reproduction of any part of this
publication are subjected to copyright

Pic. A presentation session at Pharmacy Research Colloquium

























5

HKL Research Day 2016


12th National Geriatric Conference

















Mdm Fateha Kamaruddin
Poster—Winner
Ms Hannah Abd Halim
Vancomycin initial dosing in adult dialysis (VIDAD) Poster—1st Runner-up
patients in tertiary care hospital
The use of FRIDS and Ods among hospitalised
elderly in HKL


9th National Pharmacy R&D Conference


















Ms Lee Jia Min HKL Research Day 2017
Oral—2nd Runner-up
The impact of pharmacist led patient education pro-
gram on quality of bowel preparation for colonoscopy
Mdm Anitha Ramadas
Oral—Winner
The impact of multidisciplinary
Carbapenem stewardship
Mr Ammar Kamar rounds in a tertiary hospital
Poster—3rd Runner-up (ACTION)
Observational Study On the
Prevalence of Errors Associated
with Intravenous Infusion of
Inotropes OBSPII





6

HKL Research Day 2018





3rd National Renal Pharmacy

Scientific Meeting













Ms Lee Mei Wah
Oral—1st Runner-up
Budget Impact Analysis of Fingolimod in Treatment of
Multiple Sclerosis:

Mdm Chew Chia Zin
Poster—Best Poster Award
Multicentre analysis of medication error (ME)
reports in hospitalised renal patients





National Pediatric Pharmacy

Meeting 2019


HKL CRC Research Day

























Ms Koo Kaitian Mr. Jeevanandan A/l Narayanan
Oral—3rd prize Poster— 4th place
Use of Complimentary & Alternative Medicine in Pharmacist's intervention on O&G Outpatient
Children with Atopic Eczema in Tertiary Care Centre prescription in Malaysian Tertiary Hospital

7

OUR PARTICIPATION








2016 2017 2018 2019

Diabetes Asia The 17th American College 3rd National Renal National Pediatric
2016 Conference of Clinical Pharmacy Pharmacy Scientific Pharmacy Meeting
Assessment of insulin The use of FRIDS and ODs Meeting
injection technique & amonghospitalized elderly in HKL - Multicenter analysis of med- The use of Complementary &
injection knowledge among Risks factors of falls among ication error (ME) reports in Alternative Medicine in
pen users in HKL elderly : implication of Children with Atopic Eczema
hospitalized renal patients
orthostatism drugs on patients - A knowledge, attitude & at a Tertiary Care Centre
with comorbidities practice (KAP) survey regard-
ing cadaveric organ trans-
plantation amongst pharmacy
staff of HKL

12th National Annual Scientific Meeting HKL Research Day HKL CRC Research Day
Geriatric Conference on Emerging Infectious Budget Impact Analysis of - Pharmacist’s Intervention on
The use of FRIDS and ODs Threats (ASMEIT) and Fingolimod in Treatment of O&G Outpatient Prescription
among hospitalized elderly Pre-congress Antimicrobial Multiple Sclerosis in Malaysian Tertiary Hospital
in HKL - Dipeptidyl-4 Inhibitors use in
Stewardship Workshop Type II Diabetic Patients in a
The impact of multidisciplinary Tertiary Hospital
Carbapenem stewardship rounds
in a tertiary hospital (ACTION)
9th National Pharmacy HKL Research Day Emergency Medicine An- HKL CRC Research Day
R&D Conference - The impact of multidisciplinary nual Scientific Meeting
Vancomycin initial dosing in Carbapenem stewardship rounds (EMAS) - Factors causing Missed
in a tertiary hospital (ACTION)
adult dialysis (VIDAD) - Three Factor Prothrombin Doses among Methadone
patients in tertiary care - Observational Study On the Complex Concentrate : Hos- Replacement Therapy (MRT)
hospital Prevalence of Errors Associated pital Kuala Lumpur Experi- Patients in HKL Methadone
The impact of pharmacist with Interavenous Infusion of In- ence (Case Report) Clinic
otrope(s) OBSPII
led patient education - Paroxysmal Supraventricu- - A Systematic Review on the
programme on quality of lar Tachycardia In Pregnancy Minimum Effective Dos(MED)
bowel preparation for Patient With Acute Exacerba- of Vitamin B Supplementation
colonoscopy tion of Asthma (Case report) in Diabetic Neuropathy.
HKL Research Day Neuroscience Conference NHAM Conference
- Vancomycin initial dosing
in adult dialysis (VIDAD) Budget Impact Analysis of Fenofibrate—Warfarin
patients in tertiary care Fingolimod in Treatment of Interaction : HKL Experience
hospital Multiple Sclerosis
- The impact of pharmacist
led patient education
program on quality of bowel
preparation for colonoscopy
- Assessment of insulin
injection technique &
injection knowledge among
pen users in HKL 8

2019
 (HKL) - A systemic review on the minimum effective dose (Med) of vitamin B supplementation in diabetic neuropathy
Chin Kheng Yin, Dr. Norkasihan Ibrahim, Yam Chiew Fong

 (WCH) - The Use of Complementary and Alternative Medicine in Children with Atopic Eczema at a Tertiary Care Centre
Koo Kaitian,

(WCH) - Pharmacist's intervention on O&G Outpatient prescription in Malaysian Tertiary Hospital
Jeevanandan a/l Narayanan, Dr. Shamala a/p Balan, Ong Li Ling, Precella binti Johny, Nurhamizah binti Kasim

 (HKL) - Factors causing Missed doses among Methadone Replacement Therapy (MRT) patients in Methadone Clinic, HKL
Chew Ken Wey, Kavidha A/p Mohan, Nur Syazreen, Munira Mohd. Izat, Rajesweran A/l Ramalingam, Zulsairi Mohd Pauzi

 (HKL) - Fenofibrate- Warfarin Interaction: Hospital Kuala Lumpur Experience
Chew Ken Wey, Evelyn Chee Li Ching, Nagajothy, Nirmala Jagan

2018
 (HKL) - Three Factor Prothrombin Complex Concentrate : Hospital Kuala Lumpur Experience (Case Report)
Kavidha A/p Mohan, Wilson Koh Hock Peng, Nirmala Jagan, Jivanraj Nagarajah,
Dr Nurulalnissaa Abd Kadir (Medical Specialist)

 (HKL) - Paroxysmal Supraventricular Tachycardia In Pregnanct Patient With Acute Exacerbation of Asthma (Case report)
Kavidha A/p Mohan, Wilson Koh Hock Peng, Nirmala Jagan, Jivanraj Nagarajah,
Dr Muhamad Yusof Muharam (ED Specialist)

 (WCH) - Eczema Perception and Understanding of Topical Steroid Use among Parents or Caregivers of Children with
Atopic Eczema in Malaysia
Yap Kuan Chau, Dr Noraida Mohamed Shah, Dr. Sabeera Begum, Rushitaa A/P Nagayah,
Dr. Tuan Mazlelaa Tuan Mahmood

2017
 (HKL) - Budget Impact Analysis of Fingolimod in Treatment of Multiple Sclerosis
Lee Mei Wah, Tan Ai Leen, Cheng Kai Sin, Nurul Faezah Binti Mohd Yusoff, Sabariah Pakeer Oothuman,
Rajeswaran a/l Ramalingam, Chai Yee Yien

 User Acceptance of Pharmacy Information System (PhIS): Applying the Unified Theory of Acceptance in a Pharmacy
Setting
Munirah Athirah, Dr Zaitulhusna, Munirah Athirah Kamalludin, Abdul Qayyum Zainal, Evelyn Chee Li Ching

 (HKL) - The impact of multidisciplinary Carbapenem stewardship rounds in a tertiary hospital (ACTION)
Anitha Ramadas, Teh Hwei Lin, Ching Shan Lii, Rohana Hassan, Dr Leong Chee Loon





9

2016
 (HKL) - Observational Study On the Prevalence of Errors Associated with Interavenous Infusion of Inotrope(s) OBSPII
Jasmine, Aina Fairuz, Michelle Liew, Ammar Kamar , Siti Fathimah, Elaine Than.

 (HKL) - Vancomycin initial dosing in adult dialysis (VIDAD) patients in tertiary care hospital
Siti Shahida Mohd Shaffudin, Fateha Kamaruddin , Ching Shan Lii, Nurul Hizwani Azahar, Anitha Ramadas

 (HKL) - The impact of pharmacist led patient education programme on quality of bowel preparation for colonoscopy
Sivakami, Tay Chan Yen, Michele Lim, Foo Minjia, Liew Yen Yee, Lee Jia Min, Mr. Razali, Mr. Mohan & Dr. Poobalan

 (HKL) - Wastage of unused chemotherapy medications after reconstitution
Ang Zen Yang, Safawati Samsuri, Nadiah Abdullah, Veron Lee Siao Hui, Andrew Yem Weng Hoong

 (HKL) - Dipeptidyl-4 inhibitors use in type II diabetic patients in a tertiary hospital
Nirmala a/p Jagan, Jivanraj a/l Nagarajah, Anitha a/p Ramadas, Hannah Abdul Halim, Zulsairi Mohd Pauzi, Mak Woh Yon

 (HKL) - The use of FRIDS and Ods among hospitalised elderly in HKL
Hannah, Jacqueline WHY, Rosmaliah A, Chew Chia Zin, Teh HL(Kimberly), Ammar K, Hadijah MT and Lee FS







































10

Year of Study Initiation
2015 2016 2017 2018
Number of Study Registered 3 6 7 14

Awaiting NMRR Approval 0 0 0 2
Collaborative research 1 3 1 8

Dropped 1 1 2 1
Proposal 0 0 2 6
Data Collection 0 0 1 3
Status Analysis 0 0 2 0

Manuscript 3 6 2 4
Published 0 0 0 1

Presented 3 4 2 5
Number of presentation 6 6 4 6






































11

All Research in the pharmacy facilities of HKL, WCH and IPR must be listed in (1) Pharmacy Research

Registry, (2) the National Medical Research Registry(NMRR) and (3) HKL Clinical Research Centre(CRC) if
conducted in HKL. Team members of registered studies are eligible for nominations to courses in scientific
research and funding to present research findings locally and abroad. The registration process is as follows:






Notify R&D Committee: New study details
Email new study details (Study title, Names of principle
Investigator (PI) & team members and Contact details of the
Corresponding person) to <[email protected]>. We will Present study proposal in Research Colloquium
reply with an appointment date for your team to present the Your team will be presenting to the R&D Committee who will
study proposal in one of the Research Colloquium. peer review the study proposal. The committee will suggest
corrections to be made (if any) before you can apply for NMRR.
If major corrections are involved, your team will be called for
another seating. This process is to minimise delays in obtaining
Apply for NMRR approval NMRR approval.
Register your study at website <nmrr.gov.my> for
further actions. This is compulsory for all medical
research to be conducted in MOH facilities. It usually takes 8
weeks for approval from the date of complete document
submission.

Apply for CRC HKL approval
Email Study Title, NMRR approval number and Contact details
of the Corresponding person to <[email protected]> for
further actions. It usually takes 2 weeks for approval from the
date of complete document submission.
Notify R&D Committee: NMRR &
CRC Approval Number
Email approval number to <[email protected]>






Start data collection
Should there be any problem and help is needed, you can reach
Update study progress in Research Colloquium out to R&D Committee by email <[email protected]>. One of
The Primary Investigator (PI) will be called to update the the committee members will be assigned to assist you.
th
committee on the study progress, 2 weeks before the 30 of
March, June, September and December.
You will be presenting to the R&D Committee who will assist
in the matters that hinder the study progress or if needed,
connect you to experts within or outside the department.

Update R&D KPI to PSF & MOH
The R&D Committee will have to submit the R&D KPI index to
th
PSF before the 4 of April, July, October and January. The
index are obtained from process 1 – 7. That is why your coop-
eration is highly appreciated!


12

Mesyuarat
Research JK R&D
Colloquium
(RC I) RC 2

Bengkel ISR





















Research Mesyuarat
Colloquium JK R&D
(RC 3)
























Bengkel Mesyuarat
Penulisan JK R&D
Manuskrip
Bengkel Research
Laporan Colloquium
systematic (RC 4)
review


13